FBIO
Fortress Biotech·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 3
Consensus Rating "Strong Buy"
Gap Down
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About FBIO
Fortress Biotech, Inc.
A biopharmaceutical company focused on acquiring, developing, and commercializing innovative pharmaceutical and biotechnology products
Pharmaceutical
06/28/2006
11/17/2011
NASDAQ Stock Exchange
101
12-31
Common stock
1111 Kane Concourse, Suite 301, Bay Harbor Islands, FL 33154
--
Fortress Biotech, Inc., was incorporated in Delaware on June 28, 2006. The company is a biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product income, equity holdings, and dividend and royalty income streams.
Company Financials
EPS
FBIO has released its 2025 Q2 earnings. EPS was reported at 0.45, versus the expected -0.31, beating expectations. The chart below visualizes how FBIO has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
FBIO has released its 2025 Q2 earnings report, with revenue of 16.41M, reflecting a YoY change of 10.18%, and net profit of -11.65M, showing a YoY change of 59.57%. The Sankey diagram below clearly presents FBIO's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
